Skip to main content

Table 2 Clinical and laboratory data in patients with PID

From: Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease

 

PID with chlamydia (N = 175)

PID without chlamydia (N = 322)

P

Mean temperature (°C)

37.2 ± 0.8

37.2 ± 0.9

0.893

Fever (%)

36 (20.6)

73 (22.7)

0.650

Mean WBC count x103/μl

10.3 ± 4.0

10.2 ± 4.5

0.948

Leuocytosis (%)

63 (36.0)

102 (31.7)

0.836

ESR (mm/h)

45.0 ± 26.6

23.5 ± 24.5

<0.0001

CRP (mg/dl)

7.6 ± 7.0

4.8 ± 6.5

<0.0001

CA 125 (U/mL)

130.7 ± 174.6

23.8 ± 40.0

<0.0001

Abnormal CA 125 (%, > 35 U/mL)

115 (65.7)

42 (13.0)

<0.0001

Other sexually transmitted infection (%)

 Neisseria gonorrhoeae

11(6.3)

1(0.3)

<0.0001

 Mycoplasma genitalium

13(7.4)

4(1.2)

0.001

 Mycoplasma hominis

9 (5.1)

11(3.4)

0.349

 Ureaplasma urealyticum

19(10.9)

17(5.3)

0.029

 Trichomonas vaginalis

14(8.0)

16(5.0)

0.236

 Hospital day (days)

8.2 ± 2.7

7.2 ± 2.4

0.016

 Recurrent PID (%)

9 (5.1)

5 (1.6)

0.051

 TOA (%)

45 (25.7)

24 (7.4)

<0.0001

 FHC syndrome (%)

69 (39.4)

2 (0.6)

<0.0001

 Operation (%)

39 (22.2)

32 (9.9)

<0.0001

  1. PID pelvic inflammatory disease, WBC White blood cell, ESR erythrocyte sedimentation rate, CRP C-reactive protein, TOA tubo-ovarian abscess, FHC syndrome Fitz-Hugh-Curtis syndrome